Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis

Condition:   Progressive Multiple Sclerosis
Interventions:   Drug: Placebo;   Drug: Masitinib (4.5)
Sponsor:   AB Science
Recruiting


Author: